Trimi vs IVIM Health: Compounded GLP-1

Both Trimi and IVIM Health offer compounded GLP-1 medications through telehealth programs. They share a similar core model but differ in pricing, medication breadth, and program approach. This comparison helps you understand which platform better matches your needs and budget.

Transparency Note: This comparison is published by Trimi. We encourage you to verify all competitor information directly on IVIM Health's website. Last verified: April 2026.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication.

Quick Comparison

Feature	Trimi	IVIM Health
GLP-1 medications	Compounded semaglutide, tirzepatide, retatrutide	Compounded semaglutide, compounded tirzepatide
Semaglutide pricing	$125/month	Varies (check current pricing)
Tirzepatide pricing	$125/month	Varies (check current pricing)
Provider model	Dedicated GLP-1 specialists	Telehealth providers
Pharmacy type	503B compounding pharmacy	503B compounding pharmacy
Medication included	Yes, in monthly price	Yes, in program price

Platform Overview

Trimi

Trimi is built exclusively for GLP-1 weight management with compounded semaglutide at $125/month, compounded tirzepatide at $125/month, and retatrutide. The program includes provider consultations, medication, and shipping in one flat monthly fee. All medications come from FDA-registered 503B compounding pharmacies. Providers specialize in GLP-1 therapy with expertise in titration, side effect management, and long-term weight maintenance.

IVIM Health

IVIM Health is a telehealth platform offering compounded GLP-1 medications with a focus on making weight loss treatment accessible. They provide compounded semaglutide and tirzepatide through their program, with medications sourced from compounding pharmacies. IVIM Health has built a reputation for their weight loss programs and patient support.

Where IVIM Health excels: IVIM Health has established a solid presence in the compounded GLP-1 market and offers structured weight loss programs. They have invested in patient education and support resources that help patients through their treatment journey. Their platform is straightforward and accessible.

Pricing Differences

Trimi's pricing is transparent and flat: $99/month for compounded semaglutide and $125/month for compounded tirzepatide, regardless of dose. This means your cost does not increase as you titrate to higher doses. When comparing with IVIM Health, calculate the total monthly cost at your expected maintenance dose, as pricing structures may differ between the platforms.

Over a 12-month treatment period, the difference in pricing models can add up to hundreds or thousands of dollars. Always compare total cost at your expected maintenance dose rather than introductory or starting-dose pricing.

Medication Breadth

Trimi offers three GLP-1 medications compared to the two typically available through IVIM Health. The availability of retatrutide gives Trimi patients an additional option if semaglutide or tirzepatide do not produce optimal results or cause intolerable side effects. Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, and clinical trials have shown exceptional weight loss results.

Clinical Support

Both platforms provide clinical support through telehealth consultations. Trimi's model emphasizes dedicated GLP-1 specialists with ongoing support, regular check-ins, and personalized titration plans. The depth and frequency of clinical interaction may vary between platforms, so ask about follow-up schedules and provider accessibility when evaluating each option.

Who Each Program Is Best For

Choose Trimi If:

You want the most affordable flat-rate pricing for compounded GLP-1 medications
Access to three medications (semaglutide, tirzepatide, retatrutide) matters to you
You want dedicated GLP-1 specialist providers
Predictable monthly costs without dose-dependent increases are important

Choose IVIM Health If:

You are already established with IVIM Health and satisfied with your care
Their specific program structure appeals to you
You have had positive experiences with their providers and support team
Their current pricing is competitive for your specific medication and dose

What We Admire About IVIM Health

IVIM Health has helped expand access to compounded GLP-1 medications through telehealth. They have demonstrated that quality weight loss treatment can be delivered remotely, and their patient education efforts have helped many people understand their treatment options. More providers in this space means more patients getting the help they need.

Getting Started

Compare total costs, medication options, and clinical support depth before choosing a program. To learn more about Trimi, visit our treatment options page. Compounded semaglutide starts at $99/month and tirzepatide at $125/month.

Frequently Asked Questions

Is Trimi more affordable than IVIM Health?

Trimi's flat-rate pricing of $99/month for semaglutide and $125/month for tirzepatide is designed to be competitive. Compare total monthly costs at your expected maintenance dose, including all fees, to determine which is more affordable for your specific situation.

Does IVIM Health offer retatrutide?

As of early 2026, IVIM Health primarily offers compounded semaglutide and tirzepatide. Trimi additionally offers retatrutide for patients who may benefit from the triple agonist approach.

Can I switch from IVIM Health to Trimi?

Yes. Switching between GLP-1 telehealth programs is straightforward. A Trimi provider will review your current medication, dose, and treatment response before continuing or adjusting your plan.

Do both platforms use 503B pharmacies?

Both Trimi and IVIM Health source compounded GLP-1 medications from FDA-registered 503B outsourcing facilities. This ensures medications are produced under cGMP conditions with appropriate quality controls.